32 results
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
in HIV-AIDS Preventing ... control of the infection ... #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... Penicillium marneffei Infections ... in HIV-AIDS Preventing ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... Bacterial Enteric Infections ... in HIV-AIDS Preventing ... #Treatment #management ... #HIVAIDS #pharmacology
Post-Intensive Care Syndrome (PICS)
Symptoms of PICS:
 - Physical Domain: Generalized weakness, Fatigue, Difficulty walking
 - Cognitive
Post-Intensive Care Syndrome ... Hyperglycemia PREVENTION ... guide targeted treatments ... PICS #diagnosis #management ... #criticalcare #
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
efficacy of this therapy ... Preferred Therapy ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Isospora belli Infection ... General Management ... IsosporaBelli #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
for effective treatment ... mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
mm3 Preferred Therapy ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
Hepatorenal Syndrome - Diagnosis and Management Summary
Who gets HRS?
 • Decompensated cirrhosis
 • Typically with existing
Hepatorenal Syndrome ... Diagnosis and Management ... abuse, Bacterial infection ... is vasoactive therapy ... Typically requires ICU
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
Propofol infusion syndrome ... pharmacologic therapy ... pharmacologic therapy ... #CriticalCare # ... diagnosis #management